6+ 呼気一酸化窒素濃度保険適応 References

子育て長田こどもクリニック呼気一酸化窒素測定検査(呼気NO検査) from www.kosodate-nagata.jp

Introduction

As we enter the year 2023, insurance companies are beginning to take notice of the importance of measuring exhaled nitric oxide (FeNO) levels in determining an individual's risk for respiratory disease. This non-invasive test can provide valuable information on a person's lung health, indicating the presence of inflammation in the airways. In this article, we will discuss the significance of FeNO levels for insurance coverage and what you need to know.

What is Exhaled Nitric Oxide?

Nitric oxide (NO) is a gas produced by various cells in the body, including those in the respiratory system. When inhaled air comes into contact with the lining of the airways, NO is released into the lungs and is then exhaled out of the body. The concentration of NO in exhaled breath (FeNO) can be measured using a simple and painless test that involves breathing into a device for a few seconds.

Why is FeNO Important?

FeNO levels are an indicator of airway inflammation, which is a key characteristic of respiratory diseases such as asthma. High levels of FeNO are associated with increased risk for asthma, while low levels are indicative of healthy lung function. Insurance companies are beginning to recognize the value of FeNO testing in determining an individual's risk for respiratory disease and providing appropriate coverage.

How is FeNO Measured?

FeNO testing is a non-invasive and painless procedure that can be performed in a doctor's office or clinic. The patient simply breathes into a device that measures the concentration of NO in their exhaled breath. The test takes only a few minutes to complete and is suitable for people of all ages, including children.

FeNO and Asthma

Asthma is a chronic respiratory disease that affects millions of people worldwide. It is characterized by inflammation and narrowing of the airways, leading to symptoms such as wheezing, coughing, and shortness of breath. FeNO levels are elevated in people with asthma, making this test a valuable tool for diagnosis and monitoring of the disease.

FeNO and Insurance Coverage

Insurance companies are beginning to recognize the value of FeNO testing in determining an individual's risk for respiratory disease and providing appropriate coverage. FeNO testing can help insurers identify individuals who are at high risk for asthma or other respiratory conditions, allowing them to make more informed decisions about coverage and premiums.

FeNO and Treatment

FeNO testing can also be used to monitor the effectiveness of asthma treatment. High levels of FeNO indicate ongoing airway inflammation, suggesting that treatment needs to be adjusted or intensified. Conversely, low levels of FeNO may suggest that treatment is working effectively and can be maintained at the current level.

Conclusion

In conclusion, FeNO testing is a valuable tool for assessing lung health and identifying individuals at risk for respiratory disease. Insurance companies are beginning to take notice of the importance of FeNO testing in determining appropriate coverage and premiums. If you are concerned about your lung health or have a history of respiratory disease, talk to your doctor about FeNO testing and what it could mean for you.